Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
24 hedge funds and large institutions have $27.4M invested in Sophiris Bio, Inc. in 2014 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
9% more funds holding
Funds holding: 22 → 24 (+2)
3.12% less ownership
Funds ownership: 54.03% → 50.9% (-3.1%)
17% less capital invested
Capital invested by funds: $33.1M → $27.4M (-$5.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$471K |
| 2 |
SC
Sophrosyne Capital
New York
|
+$368K |
| 3 |
Bank of New York Mellon
New York
|
+$49K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.32K |
| 5 |
Citigroup
New York
|
+$1.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.85M |
| 2 |
First Manhattan
New York
|
-$974K |
SPHS Hedge Fund Activity: Q1 2014 in Review
24 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2014, worth a combined $27.4M — down 17% from $33.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SPHS positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Great Point Partners, adding an estimated $471K. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.85M sold.
- 24 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2014, up from 22 in Q4 2013.
- Funds reported $27.4M of Sophiris Bio, Inc. stock for Q1 2014, down 17% quarter-over-quarter.
- 3 funds opened new Sophiris Bio, Inc. positions in Q1 2014 and 1 closed out, a net change of +2 holders.
- The largest Sophiris Bio, Inc. buyer in Q1 2014 was Great Point Partners, an estimated $471K added.
- The largest Sophiris Bio, Inc. seller in Q1 2014 was Tang Capital Management, an estimated $1.85M sold.
Based on aggregated 13F filings for Q1 2014.